Increased alveolar and plasma gelatinases activity during postpump syndrome: Inhibition by inhaled nitric oxide

Journal of Cardiovascular Pharmacology

Volumn 48, Issue 3, 2006, Pages 71-78

  Hubert, Bernard ^a,b   Troncy, Eric ^c   Gauvin, Dominique ^a   Taha, Rame ^a   Pang, Daniel ^c   Beauchamp, Guy ^c   Radomski, Anna ^d,e   Radomski, Marek W ^d,e   Blaise, Gilbert A ^a,f  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f NOTRE DAME HOSPITAL   (Canada)

Author keywords

Cardiopulmonary bypass; Inflammation; Lung; Matrix metalloproteinases; NO gas

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GELATINASE; GELATINASE A; GELATINASE B; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; NONHUMAN; PLASMA; POSTPUMP SYNDROME; PRIORITY JOURNAL; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ZYMOGRAPHY;

ANIMALS; BRONCHI; CELL COUNT; GELATINASES; INFLAMMATION; INHALATION; MALE; NITRIC OXIDE; SWINE; SYNDROME; TIME FACTORS;

EID: 33749820666     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000242054.66031.5c     Document Type: Article

References (42)

1. Parks WC, Mecham RP. Matrix Metalloproteinases. San Diego: Academic Press; 1998.
2. Lagente V, Manoury B, Nénan S, et al. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res. 2005;38:1521-1530.
3. Shah PK. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation. 1997;96:2115-2117.
4. Carney DE, Lutz CJ, Picone AL, et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation. 1999;100:400-406.
5. Benjamin IJ. Matrix metalloproteinases: from biology to therapeutic strategies in cardiovascular disease. J Invest Med. 2001;49:381-397.
6. Yao PM, Maitre B, Delacourt C, et al. Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1β and TNF-α. Am J Physiol. 1997;273:L866-L874.
7. Asimakopoulos G, Smith PLC, Ratnatunga CP, et al. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg. 1999;68:1107-1115.
8. Taggart DP, el Fiky M, Carter R, et al. Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1123-1128.
9. Gott JP, Cooper WA, Schmidt FE Jr, et al. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg. 1998;66:747-754.
10. Rady MY, Ryan T, Starr NJ. Early onset of acute pulmonary dysfunction after cardiovascular surgery: risk factors and clinical outcome. Crit Care Med. 1997;25:1931-1839.
11. Joffs C, Gunasinghe HR, Multani MM, et al. Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases. Ann Thorac Surg. 2001;71:1518-1523.
12. Steinberg J, Fink G, Picone A, et al. Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass. J Extrac orpor Technol. 2001;33:218-222.
13. Mayers I, T Hurst T, Puttagunta L, et al. Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J Thorac Cardiovasc Surg. 2001;122:746-752.
14. Torii K, Iida K, Miyazaki Y, et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med. 1997;155:43-46.
15. Cheung PY, Sawicki G, Wosniak M, et al. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation. 2001;101:1833-1839.
16. Rossaint R, Gerlach H, Schmidt-Ruhnke H, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest. 1995;107:1107-1115.
17. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
18. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651-4655.
19. Mayers I, Salas E, Hurst T, et al. Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by s-nitrosoglutathione. J Thorac Cardiovasc Surg. 1999;117:1009-1016.
20. Sawicki GE, Salas E, Murat J, H et al. Release of gelatinase A during platelet activation mediates aggregation. Nature. 1997;386:616-619.
21. Mayers I, Hurst T, Radomski A, et al. Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger. J Thorac Cardiovasc Surg. 2003;125:661-668.
22. Marcet-Palacios M, Graham K, Cass C, et al. Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. JPET. 2003;307:429-436.
23. Picone A, Lutz C, Finck C, et al. Multiple sequential insults cause post-pump syndrome. Ann Thorac Surg. 1999;67:978-985.
24. Nieman G, Searles B, Carney D, et al. Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment. J Extrac orpor Technol. 1999;31:202-210.
25. Hubert M, Salazkin I, Desjardins J, et al. Cardiopulmonary bypass surgery in swine: a research model. J Exp Anim Sci. 2003;43:135-149.
26. Shah N, Nakayama D, Jacob T, et al. Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch Surg. 1994;129:158-164.
27. Dube L, Francoeur M, Troncy E, et al. Comparison of two administration techniques of inhaled nitric oxide on nitrogen dioxide production. Can J Anaesth. 1995;42:922-927.
28. Troncy E, Hubert B, Pang D, et al. Pre-emptive and continuous inhaled NO counteracts the cardiopulmonary consequences of extracorporeal circulation in a pig model. Nitric Oxide Biol Chem. 2006;14:261-271.
29. El Kebir D, Taha R, Hubert B, et al. The anti-inflammatory effect of inhaled nitric oxide on pulmonary inflammation in a swine model. Can J Physiol Pharmacol. 2005;83:252-258.
30. El Kebir D, Hubert B, Taha R, et al. Effects of inhaled nitric oxide on inflammation and apoptosis after cardiopulmonary bypass. Chest. 2005;128:2910-2917.
31. Sawicki G, Sanders E, Salas E, et al. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost. 1998;80:836-839.
32. Fox-Robichaud A, Payne D, Hasan S, et al. Inhaled NO as a viable antiadhesive therapy for ischemia-reperfusion injury of distal microvascular beds. J Clin Invest. 1995;96:60-68.
33. Samama C, Diaby M, Fellahi J, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patient with acute respiratory distress syndrome. Anesthesiology. 1995;83:56-65.
34. Chung A, Wildhirt S, Wang S, et al. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study. J Thorac Cardiovasc Surg. 2005;129:782-790.
35. Gianetti J, Del Sarto P, Bevilacqua S, et al. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg. 2004;127:44-50.
36. Anderson B, Moore E, Banerjee A. Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure. J Surg Res. 1994;56:199-205.
37. Kim F, Moore E, Moore F, et al. Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. J Surg Res. 1996;58:636-640.
38. Waisman D, Brod V, Dickstein R, A et al. Effects of inhaled nitric oxide on lung injury after intestinal ischemia-reperfusion in rats. Shock. 2005;23:150-155.
39. Hozumi A, Nishimura Y, Nishiuma T, et al. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1444-L1452.
40. Albert J, Radomski A, Soop A, et al. Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol Scand. 2003;47:407-410.
41. Okamoto T, Valacchi G, Gohil K, et al. S-nitrosothiols inhibit cytokine-mediated induction of matrix metalloproteinase-9 in airway epithelial cells. Am J Respir Cell Mol Biol. 2002;27:463-473.
42. Akool E, Doller A, Müller R, et al. Nitric oxide induces TIMP-1 expression by activating the transforming growth factorb-Smad signaling pathway. J Biol Chem. 2005;280:39403-39416.